CSI Market
Sign In | Register

Foghorn Therapeutics Inc (FHTX) - News Archive

Showing 10 of 10 results.

Foghorn Therapeutics Inc Faces Market Performance Challenge Amidst Industry Growth

In recent weeks, it appears that Foghorn Therapeutics Inc s shares have been trailing the performance of the entire market. This article aims to analyze this trend by interpreting relevant articles and shedding light on...

Jul 12, 2024 • Major Pharmaceutical Preparations Industry Stocks on the Move Google Phase July Flagship July Pharmaceuticals Fo
Foghorn Therapeutics Inc, a biotechnology company based in Cambridge, Massachusetts, recently made an announcement regarding the pricing of their registered direct offering of common stock and pre-funded warrants The offering includes 12,743,039 shares of common stock priced at $551 per share, alongside pre-funded warrants to purchase up to 7,220,794 shares of common stock at a price of $55099 per pre-funded warrant The offering is expected to close on or around May 22, 2024, subject to customary closing conditions It is noteworthy that all the shares of common stock to be sold in this offering are offered by Foghorn itself

Foghorn Therapeutics Inc, a biotechnology company based in Cambridge, Massachusetts, recently made an announcement regarding the pricing of their registered direct offering of common stock and pre-funded warrants. The o...

May 20, 2024 • Major Pharmaceutical Preparations Industry Shares